Estrogen receptor modulators

Details for Australian Patent Application No. 2002305359 (hide)

Owner Merck & Co., Inc.

Inventors Morgan, Jerry Dwain; Mosley, Ralph Troy; Blizzard, Timothy Allen; Hammond, Milton Lloyd

Agent Spruson & Ferguson

Pub. Number AU-B-2002305359

PCT Number PCT/US02/14054

PCT Pub. Number WO2002/091993

Priority 60/290,169 10.05.01 US

Filing date 6 May 2002

Wipo publication date 25 November 2002

Acceptance publication date 26 May 2005

International Classifications

C07C 013/38 Cyclic hydrocarbons containing rings other than, or in addition to, six-membered aromatic rings

Event Publications

19 December 2002 Complete Application Filed

  Priority application(s): 60/290,169 10.05.01 US

1 May 2003 Application Open to Public Inspection

  Published as AU-B-2002305359

26 May 2005 Application Accepted

  Published as AU-B-2002305359

22 September 2005 Standard Patent Sealed

4 December 2008 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002305360-THERAPEUTIC COMPISITIONS AND METHODS FOR THE INHIBITION OF ANGIOGENESIS

2002305358-QUADRATURE ALIGNMENT IN COMMUNICATIONS RECEIVERS